Aerobic vs. Aerobic + Yoga Exercise for Obesity
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn whether adding yoga exercise to a behavioral weight loss intervention improves weight loss in adults with overweight or obesity. It will also provide information about whether this approach to weight loss has additional benefits on other health and fitness measurements. The main questions it aims to answer are: * Is there a difference in weight loss between the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? * Is there a difference in how much physical activity is completed between the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? * Is there a difference in the change in body composition (fat mass, lean body mass) between the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? * Is there a difference in the change in cardiorespiratory fitness the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? * Is there a difference in the change in muscle strength between the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? * Is there a difference in the change in resting blood pressure between the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? * Is there a difference in the change in food intake or eating behaviors between the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? * Is there a difference in the change in feelings of stress or mood between the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? * Is there a difference in the change in sleep between the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? * Is there a difference in the change in mindfulness between the behavioral program that includes aerobic exercise plus yoga compared to the behavioral program that includes only aerobic exercise? Participants will: * Participate in a weight loss program for a period of 12 months that involves attending behavioral weight loss sessions. This involves coming to a session at the research center weekly for the initial 6 months and then every other week for the remaining 6 months. * Attempt to reduce the amount of food that they eat to reduce the calories they consume. * Participate in a combination of aerobic exercise plus yoga or just aerobic exercise. * Keep a record of the food they consume, use a digital scale provided to them, and wear an activity tracker provided to them for the period of 12 months. * Visit the clinical before starting the weight loss program, after 3 months, 6 months, 9 months, and 12 months to complete measurements of their weight and other measurements to monitor their progress. * Complete exercise sessions in the clinic between weeks 2-6, at month 6, and at month 12 to provide information about how they response to a single session of exercise.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on anti-obesity medication, you cannot participate in the trial.
What data supports the effectiveness of the treatment Aerobic + Yoga Exercise for obesity?
Research shows that both yoga and aerobic exercise can improve quality of life and reduce obesity-related measures like body mass index (BMI) and waist circumference. Combining these activities may enhance these benefits, as yoga can also promote healthy eating and provide social support, which are important for weight loss.12345
Is Aerobic + Yoga Exercise safe for humans?
How does the Aerobic + Yoga Exercise treatment for obesity differ from other treatments?
The Aerobic + Yoga Exercise treatment is unique because it combines traditional aerobic exercise with yoga, which may enhance weight loss and improve quality of life by incorporating both physical activity and mindfulness practices. This dual approach can offer benefits such as improved flexibility, stress reduction, and a more holistic lifestyle change compared to standard exercise or diet plans alone.235910
Research Team
John M. Jakicic, PhD
Principal Investigator
University of Kansas Medical Center
Eligibility Criteria
This trial is for adults with overweight or obesity who want to lose weight. Participants will join a 12-month behavioral weight loss program, which includes dieting, exercise sessions, and health monitoring. They must be willing to reduce food intake, attend regular sessions at the research center, and keep track of their eating and activity.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 12-month behavioral weight loss program with either aerobic exercise or aerobic exercise plus yoga, including weekly sessions for the first 6 months and bi-weekly sessions for the remaining 6 months.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with measurements taken at 3, 6, 9, and 12 months.
Treatment Details
Interventions
- Aerobic + Yoga Exercise (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
Dr. Steve Stites
University of Kansas Medical Center
Chief Executive Officer
MD from University of Kansas School of Medicine
Dr. Matthias Salathe
University of Kansas Medical Center
Chief Medical Officer
MD from University of Kansas School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Dr. Griffin P. Rodgers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chief Executive Officer since 2007
MD, M.A.C.P.
Dr. Griffin P. Rodgers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chief Medical Officer since 2007
MD, M.A.C.P.